Clinical Trials Browser

Completed × Prostatic Neoplasms, Castration-Resistant × 90 days × Clear all

NCT05848011 2026-04-17

A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms, Castration-Resistant

NCT05968599 2026-02-25

A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer

2,731 enrolled 14 charts

Prostatic Neoplasms, Castration-Resistant